Petros Pharmaceuticals In... (PTPI)
NASDAQ: PTPI
· Real-Time Price · USD
0.03
-0.00 (-10.18%)
At close: Jun 09, 2025, 3:15 PM
Petros Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.26M | -9.27M | -2.22M | -662.03K | -2.16M | 318.15K | -4.55M | -2.55M | -1.39M | -4.22M | -13.83M | -1.81M | -174.22K | -8.19M | -1.7M | -2.11M | 3.01M |
Depreciation & Amortization | n/a | 667.29K | 768.26K | 754.67K | 753.53K | 934.79K | 826.79K | 826.79K | 826.79K | 916.27K | 1.56M | 1.56M | 1.56M | 1.69M | 1.73M | 1.73M | 1.73M |
Stock-Based Compensation | 80.04K | -270K | 60K | 16.83K | 290.38K | 212.74K | 30.84K | 43.32K | 130.34K | 228.84K | 308.14K | 302.26K | 355.83K | 126.47K | 53.17K | 680.5K | 445.01K |
Other Working Capital | n/a | -128.43K | -148.37M | 784.05K | 971.39K | 176.03K | -839.45K | 1.27M | 150.5K | -804.31K | 835.35K | -702.59K | 440.4K | -858.19K | -2.04M | -1.62M | 845.13K |
Other Non-Cash Items | n/a | 7.62M | -203.12K | -1.49M | -1.77M | 19.62K | 3.69M | 11.52K | -142.1K | 113.89K | -35.17K | -6.49M | -4M | 27.14K | 6.9K | -2.58M | 37.66K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -5.37M | -1.9M | -41.02K | n/a | n/a | n/a | 6.7M | n/a | 174.53K | -1.64M | 6.7K | -5.33M |
Change in Working Capital | n/a | 2.23M | 824.28K | -278.79K | 1.76M | 1.62M | -1.79M | 1.13M | -178.25K | 1.39M | 2.78M | -4.46M | -3.01M | -2.14M | 339.76K | 372.66K | -338.37K |
Operating Cash Flow | -1.49M | 965.4K | -771.25K | -1.66M | -1.13M | -2.26M | -3.69M | -572.07K | -748.36K | -1.57M | -1.75M | -4.2M | -5.28M | -8.3M | -1.21M | -1.9M | -446.58K |
Capital Expenditures | n/a | -5.45K | -19.14K | 2.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -5.45K | -19.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | -385.49K | -379.79K | n/a | -374.18K | -368.65K | -363.2K | -357.83K | -185.06K | -361.95K | -176.97K | -900K | -1.74M | -1.68M | -1.64M | -2.13M |
Common Stock Repurchased | n/a | -1.14M | 2.7M | -1.58M | -1.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -275.17K | n/a | n/a | n/a | n/a | -556.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | -1.12M | -2M | 15M | n/a | n/a | n/a | n/a | n/a | n/a | 25.76M | n/a | n/a | n/a |
Financial Cash Flow | n/a | -1.14M | -2.77M | -1.96M | -1.12M | -2.37M | 11.09M | -363.2K | -357.83K | -185.06K | -361.95K | -176.97K | -900K | 24.02M | -1.68M | -1.64M | -2.13M |
Net Cash Flow | 7.05M | -184.71K | -3.57M | -3.62M | -2.26M | -4.63M | 12.33K | -935.27K | -1.11M | -1.76M | -2.11M | -4.38M | -6.18M | 15.71M | -2.9M | -3.54M | -2.57M |
Free Cash Flow | -1.49M | 959.96K | -790.38K | -1.66M | -1.13M | -2.26M | -3.69M | -572.07K | -748.36K | -1.57M | -1.75M | -4.2M | -5.28M | -8.3M | -1.21M | -1.9M | -446.58K |